advertisement

Cancer

28 October 2011

Aspirin slashes hereditary cancer risk

Taking two aspirin a day for two years reduces the long-term risk of colon cancer in people at genetically higher risk by around 60%, according to a British study.

Taking two aspirin a day for two years reduces the long-term risk of colon cancer in people at genetically higher risk by around 60%, according to a British study.

John Burn of Newcastle University believes his study – the first randomized controlled trial into the effect of aspirin on cancer outcomes – is a key piece of evidence validating the case for aspirin.

Lynch syndrome

 

Read Health24’s Comments Policy

Comment on this story
0 comments
Comments have been closed for this article.

Ask the Expert

Cancer expert

CANSA’s purpose is to lead the fight against cancer in South Africa. Its mission is to be the preferred non-profit organisation that enables research, educates the public and provides support to all people affected by cancer. Questions are answered by CANSA’s Head of Health Professor Michael Herbst. For more information, visit cansa.org.za.

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules